miR-21 modulates cell apoptosis by targeting multiple genes in renal cell carcinoma

Aimin Zhang1, Yi Liu, Yizhen Shen

  • 1Department of Urology, Jinan General Hospital of PLA, Ji'nan, China. aiminzhang2000@126.com

Urology
|August 9, 2011
PubMed
Abstract

Insights

MicroRNA-21 (miR-21) promotes renal cell carcinoma by inhibiting apoptosis. Reducing miR-21 triggers cancer cell death by activating caspase pathways and downregulating key targets like TIMP3.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Renal cell carcinoma (RCC) is a significant health concern.
  • MicroRNAs (miRNAs) are increasingly recognized as critical regulators in cancer development.
  • The specific role of miR-21 in RCC pathogenesis requires further elucidation.

Purpose of the Study:

  • To investigate the mechanistic role of miR-21 in the development of renal cell carcinoma (RCC).
  • To identify the downstream targets of miR-21 involved in apoptosis regulation within RCC cells.

Main Methods:

  • Antisense oligonucleotides were used to repress miR-21 expression in RCC cells.
  • Cell proliferation and apoptosis assays were performed.
  • Western blot and luciferase reporter assays were employed to detect target gene expression (Fas ligand, TIMP3) and activity.
  • Transfection studies with modified TIMP3 were conducted to assess its role.

Main Results:

  • Repression of miR-21 significantly inhibited RCC cell proliferation and induced apoptosis via caspase pathway activation.
  • Bioinformatic analysis predicted and experimental validation confirmed that miR-21 targets multiple apoptosis-related genes, including Fas ligand and TIMP3.
  • TIMP3, when introduced without its 3' untranslated region, abrogated miR-21-mediated cell survival, indicating its crucial role.

Conclusions:

  • miR-21 is a key oncogenic factor in renal cell carcinoma.
  • miR-21 regulates cancer cell apoptosis by targeting multiple genes, including TIMP3.
  • Targeting miR-21 presents a potential therapeutic strategy for renal cell carcinoma.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...